⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001636236

Danilkovitch Alla

Reports to the SEC for 1 company · COLUMBIA, MD

Transactions

19

Companies

1

Filings

4

CIK

0001636236

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-04-17	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−25K sh	—	—	0
2019-04-17	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−6,000 sh	—	—	0
2019-04-17	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−10K sh	—	—	0
2019-04-17	OSIRIS THERAPEUTICS, INC.Non-Qualified Stock Option (right to buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−1,436 sh	—	—	0
2019-04-17	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−18.6K sh	—	—	0
2019-04-17	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−7,644 sh	—	—	0
2019-04-17	OSIRIS THERAPEUTICS, INC.Non-Qualified Stock Option (right to buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−17.4K sh	—	—	0
2019-04-17	OSIRIS THERAPEUTICS, INC.Non-Qualified Stock Option (right to buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−25K sh	—	—	0
2019-04-17	OSIRIS THERAPEUTICS, INC.D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−9,375 sh	$19.00	−$178K	0
2019-04-17	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−8,000 sh	—	—	0
2019-04-17	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−5,000 sh	—	—	0
2019-04-17	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−9,000 sh	—	—	0
2017-07-19	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+34.5K sh	$6.80	+$235K	125,534
2017-07-19	OSIRIS THERAPEUTICS, INC.Non-qualified Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+15.5K sh	$6.80	+$105K	139,000
2015-11-19	OSIRIS THERAPEUTICS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,000 sh	$5.08	+$20.3K	11,950
2015-11-19	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,000 sh	$5.08	−$20.3K	89,000
2015-08-10	OSIRIS THERAPEUTICS, INC.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−5,000 sh	$0.40	−$2,000	93,000
2015-08-10	OSIRIS THERAPEUTICS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+5,000 sh	$0.40	+$2,000	10,375
2015-08-10	OSIRIS THERAPEUTICS, INC.S Sale	Chief Scientific Officer	SSale	−2,425 sh	$18.22	−$44.2K	7,950

Recent filings

4

Accepted (ET)
Apr 174
Danilkovitch Alla0001104659-19-021850
SEC(opens sec.gov)
Sep 284
Danilkovitch Alla0001123292-17-001446
SEC(opens sec.gov)
Nov 204
OSIRIS THERAPEUTICS, INC.0001179110-15-015239
SEC(opens sec.gov)
Aug 114
OSIRIS THERAPEUTICS, INC.0001179110-15-011953
SEC(opens sec.gov)

Companies

1

OSIRIS THERAPEUTICS, INC.Chief Scientific Officer

Address

C/O OSIRIS THERAPEUTICS, INC. 7015 ALBERT EINSTEIN DRIVE

COLUMBIA, MD, 21046-1707